Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation: United Kingdom Thursday, January 15, 2026, 09:00 Hrs [IST] The ...

The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments ...

In any event, if you get caught foul (sometimes quite literally) of runner’s trots, try to take a break, slow down and ...

QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials ...

Deep inside the brain, every thought and memory begins with a burst of electrical activity. For years, scientists have tried ...

The tobacco industry rebranded a brutally addictive drug from deadly to desirable—and the longer-term health consequences may ...

How the tobacco industry rebranded a brutally addictive drug from deadly to desirable—and what it means for our health.

Patients seem to love the combination of face-to-face therapy with an online component; human therapists, not so much.

MindWalk Holdings Corp. ("MindWalk" or the "Company") today announced the discovery and validation of monoclonal antibodies and intrabodies that selectively target misfolded, pathogenic TDP-43, a ...

Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnings Per Share by Approximately $0.25 in 2026 and Approximately $0.60 in 2027 –– Exercises Option to ...

Cereno Scientific , an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced the publication of the first peer ...

The third-line results build on equally compelling second-line data, where pelareorep achieved a 30% response rate, more than doubling the 13.8% benchmark for the only FDA-approved immunotherapy in ...